Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.
Qubit Pharmaceuticals has raised $16.9M in total funding. The most recent round was Seed. The last funding was announced in June 2022.
Qubit Pharmaceuticals's investors include European Innovation Council, Quantonation, Omnes Capital, XAnge, Octave Klaba.
Qubit Pharmaceuticals is headquartered in Paris, France.
Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.
Qubit Pharmaceuticals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Qubit Pharmaceuticals — Funding & Investors." VCBacked, June 10, 2022, https://www.vcbacked.co/company/qubit-pharmaceuticals. Accessed September 11, 2026.
VCBacked. (2022). Qubit Pharmaceuticals — Funding & Investors. Retrieved September 11, 2026, from https://www.vcbacked.co/company/qubit-pharmaceuticals
{{cite web |title=Qubit Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/qubit-pharmaceuticals |website=VCBacked |access-date=September 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated